当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Burhz Hoklley
Insulin polyphagia, liver fat accumulation, and choline have gained considerable attention in the field of metabolic research. Insulin polyphagia refers to excessive hunger and increased food consumption resulting from insulin resistance. Non-alcoholic fatty liver disease (NAFLD) is characterized by abnormal fat accumulation in the liver, often associated with insulin resistance. Choline, an essential nutrient, has emerged as a potential modulator of these metabolic processes. This abstract provides a concise overview of the interplay between insulin polyphagia, liver fat, and choline. Insulin polyphagia arises from disrupted insulin signaling and is commonly observed in conditions such as obesity and type 2 diabetes. Hyperinsulinemia, a hallmark of insulin resistance, disturbs the normal feedback loop between insulin and appetite regulation centers in the brain, leading to increased hunger and overeating. NAFLD, closely linked to insulin resistance, encompasses a range of liver conditions characterized by excess fat accumulation. Elevated insulin levels promote fat synthesis and hinder fat oxidation in the liver, resulting in hepatic steatosis. Insulin resistance further exacerbates metabolic disturbances by impairing the suppression of hepatic glucose production.